Clinical Trial Update: Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion [NA]

View source ↗

Summary

Clinical trial comparing the Hemanext ONE System to conventional red blood cell transfusion; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• Hemanext ONE System

Snippet

Sponsor: Hemanext | Conditions: Hematologic Neoplasms | NA | Status: RECRUITING